Global Cord Blood Corp’s joint provisional liquidators furnished their seventeenth report to the Court on September 1, 2026. Investors can review the report through the company website and the GT Creditor Update Page, while John Royle signed the related report as joint provisional liquidator on September 3, 2026.
Key Highlights
- The latest report is identified as the Seventeenth Report.
- Investors can find the report on Global Cord Blood Corp’s website and on the GT Creditor Update Page operated by Grant Thornton.
- John Royle signed the Seventeenth Report on behalf of Global Cord Blood Corp on September 3, 2026.
Seventeenth Report Available Online
Investors can access the document online through channels identified by the company. The report is available on Global Cord Blood Corp’s website and on the GT Creditor Update Page operated by Grant Thornton. The latest report is identified as the Seventeenth Report. John Royle signed the report on behalf of Global Cord Blood Corp on September 3, 2026. The document is also connected with the company’s creditor update materials, where the report can be reviewed alongside the listed earlier reports.
FAQs
Q: What is the latest Global Cord Blood Corp court report?
A: The latest report is identified as the Seventeenth Report. It is available online through Global Cord Blood Corp’s website and the GT Creditor Update Page operated by Grant Thornton.
Q: Where can investors find the Global Cord Blood report?
A: Investors can find the report on Global Cord Blood Corp’s website and on the GT Creditor Update Page operated by Grant Thornton. It can also be reviewed with the company’s listed earlier reports.
Q: Who signed Global Cord Blood Corp’s latest report?
A: John Royle signed the Seventeenth Report on behalf of Global Cord Blood Corp on September 3, 2026. The report is connected with the company’s creditor update materials.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.